HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

Pediatric Oncology

Pediatric Oncology

We’re here for you. Call us at 844-346-7222 or

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.

59 Clinical Trials
Pediatric Oncology Phase III Enrolling
nct/study# NCT06513962 / COG-ALTE2131

Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults with Cancer

Learn More
Pediatric Oncology N/A Enrolling
nct/study# NCT05705531 / COG-ALTE21C1

Assessment of Clonal Hematopoiesis and Its Relationship to Cardiovascular Disease in Hodgkin Lymphoma Survivors

Learn More
Pediatric Oncology N/A Enrolling
nct/study# NCT05702645 / COG-ALTE22C1

Chronic Health Conditions in Down Syndrome-Associated Acute Leukemia: The Down Syndrome Phenotyping Acute Leukemia Study in Survivors (DS-PALS Survivors)

Learn More
Pediatric Oncology Phase III Enrolling
nct/study# NCT03126916 / COG-ANBL1531

A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL) (IND# 134379)

Learn More
Pediatric Oncology Phase III Enrolling
nct/study# NCT06172296 / COG-ANBL2131

A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma

Learn More
Pediatric Oncology Phase II Enrolling
nct/study# NCT05828069 / COG-ANHL2121

Phase 2 Study of Tovorafenib (DAY101) in Relapsed and Refractory Langerhans Cell Histiocytosis

Learn More

We are here for you

For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.